Table 1.
Patient characteristics and diagnosis information.
| Patient ID | Age | Diagnosis | Specimen resection site | Primary tumor location | Prior cancer treatments |
|---|---|---|---|---|---|
| HUSOV1 | 57 | HGSC Stage IIIB | Ovary | Fallopian tube | – |
| HUSOV2 | 76 | HGSC Stage IVB | Greater omentum | Fallopian tube | – |
| HUSOV3 | 75 | HGSC Stage IVB | Greater omentum | Fallopian tube |
Carboplatin+ paclitaxel |
| HUSOV4 | 79 | HGSC Stage IVB | Greater omentum | Fallopian tube | – |
| HUSOV5 | 76 | HGSC Stage IVB | Greater omentum | Fallopian tube | – |
| HUSOV6 | 35 | LGSC Stage IVB | Greater omentum | Ovary | – |
| HUSOV9 | 50 | HGMEC of ovary (clear cell and endometrioid). Stage IC2 | Ovary | Left ovary | – |
| HUSOV10 | 65 | HGSC Stage IVB | Greater omentum | Left ovary |
Carboplatin+ paclitaxel |
| HUSOV12 | 73 | HGSC Stage IVB | Greater omentum | Fallopian tube | Carboplatin |
| HUSOV13 | 66 | HGSC Stage IVB | Greater omentum | Ovary | – |
| HUSOV15 | 79 | HGSC Stage IVB | Ovary | Right ovary | Carboplatin |
| HUSOV16 | 62 | HGSC Stage IVB | Greater omentum | Fallopian tube |
Carboplatin+ paclitaxel |
Partial data was published as Quixabeira et al., 2022 at ESMO Immuno-Oncology 2022.
HGSC high grade serous carcinoma, LGSC low grade serous carcinoma.